Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Equity Ratio: 2011-2017

Historic Equity Ratio for Tenax Therapeutics (TENX) over the last 4 years, with Sep 2017 value amounting to 0.92.

  • Tenax Therapeutics' Equity Ratio rose 18.14% to 0.92 in Q3 2017 from the same period last year, while for Sep 2017 it was 0.92, marking a year-over-year increase of 18.14%. This contributed to the annual value of 0.73 for FY2016, which is N/A change from last year.
  • According to the latest figures from Q3 2017, Tenax Therapeutics' Equity Ratio is 0.92, which was up 10.28% from 0.84 recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Equity Ratio ranged from a high of 0.92 in Q3 2017 and a low of -0.56 during Q2 2013.
  • For the 3-year period, Tenax Therapeutics' Equity Ratio averaged around 0.81, with its median value being 0.79 (2016).
  • Its Equity Ratio has fluctuated over the past 5 years, first crashed by 569.11% in 2013, then increased by 18.14% in 2017.
  • Tenax Therapeutics' Equity Ratio (Quarterly) stood at -0.56 in 2013, then reached 0.83 in 2015, then fell by 11.29% to 0.73 in 2016, then rose by 18.14% to 0.92 in 2017.
  • Its Equity Ratio was 0.92 in Q3 2017, compared to 0.84 in Q2 2017 and 0.74 in Q1 2017.